RxDoctor Payments Data

Roman Krivochenitser, MD

Glaucoma Specialist · Grand Rapids, MINPI 1336553874

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $29,450 of the $40,574 with a category attached, or 72.6%. Alcon accounts for 87.5% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $20,778, more than ten times the $90 reported in 2019.

$40,574in general payments, 2019–2025

Across 202 payments — averaging $200.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$35K
  • Sight Sciences, Inc.$2K
  • AbbVie$1K
  • Aerie Pharmaceuticals, Inc.$168
  • Bausch & Lomb Americas Inc.$136
  • Carl Zeiss Meditec USA, Inc.$112
  • plus $835 from 19 others

What the payments were for

  • Consulting fees$1,0002%
  • Speaking & faculty fees$29,45073%
  • Travel & lodging$2,1365%
  • Food & beverage$7,94320%
  • Gifts$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few glaucoma specialist providers in Michiganto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$167,075
Medicare patients
305
Services billed
1,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate396$19,504
Ketorolac Tromethamine380$7,901
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol33$7,768
Latanoprost570$7,262
Cyclosporine11$3,625
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat163$2,900
Brimonidine Tartrate58$1,669
Tobramycin-DexamethasoneTobramycin/Dexamethasone21$976
Ofloxacin45$902
Timolol Maleate54$796
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha54$686
Dorzolamide Hcl11$328
Methylprednisolone25$129
Prednisone15$128

Paid to pharmacies, not to this prescriber.

Other glaucoma specialist in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →